Mirikizumab |
| رقم الكتالوجGC72429 |
Mirikizumab (LY3074828) هو جسم مضاد وحيد النسيلة من نوع IgG4 يستهدف الوحدة الفرعية p19 من الانترلوكين 23.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1884201-71-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis.
References:
[1]. Jefremow A, et al. Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical Perspective. Immunotargets Ther. 2020 Nov 26;9:289-297.
Review for Mirikizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Mirikizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *